Pasar al contenido principal

NUEVA APROXIMACION EXPERIMENTAL PARA LA IDENTIFICAICON DE ANTIPSICOTICOS ACTIVOS FRENTE AL DEFICIT COGNITIVO EN ESQUIZOFRENIA

PID2020-119428RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DE SANTIAGO DE COMPOSTELA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

  • Kossatz de Mello, Elk, 1977-
  • Diez Alarcia, Rebeca
  • Gaitonde, Supriya A.
  • Ramon Duaso, Carla, 1987-
  • Stepniewski, Tomasz Maciej, 1988-
  • Aranda García, David
  • Muneta Arrate, Itziar
  • Tepaz, Elodie
  • Saen-Oon, Suwipa
  • Soliva, Robert
  • Shahraki, Aida
  • Moreira, David
  • Brea, José
  • Loza, María I.
  • Torre Fornell, Rafael de la
  • Kolb, Peter
  • Bouvier, Michel
  • Meana, J. Javier
  • Robledo, Patricia, 1958-
  • Selent, Jana
G protein-coupled receptors (GPCRs) are sophisticated signaling machines able to simultaneously elicit multiple intracellular signaling pathways upon activation. Complete (in)activation of all pathways can be counterproductive for specific therapeutic applications. This is the case for the serotonin 2 A receptor (5-HT2AR), a prominent target for the treatment of schizophrenia. In this study, we elucidate the complex 5-HT2AR coupling signature in response to different signaling probes, and its physiological consequences by combining computational modeling, in vitro and in vivo experiments with human postmortem brain studies. We show how chemical modification of the endogenous agonist serotonin dramatically impacts the G protein coupling profile of the 5-HT2AR and the associated behavioral responses. Importantly, among these responses, we demonstrate that memory deficits are regulated by Gαq protein activation, whereas psychosis-related behavior is modulated through Gαi1 stimulation. These findings emphasize the complexity of GPCR pharmacology and physiology and open the path to designing improved therapeutics for the treatment of stchizophrenia., This work was supported by the ERAnet NEURON consortium fund (funding was provided by CIHR NDD-161471 and FRQ-S 278647 for M.B., the German Federal Ministry of Education and Research under grant number 01EW1909 for P.K., as well as the Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional number AC18/00030 for J.S. and P.R.). This work was further supported by the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI18/00094) to J.S. and (PI18/00053) to P.R. We acknowledge grant support from Agencia Estatal de Investigación (PID2020-119428RB-I00; SAF2017-88126R), Basque Government (IT-1211/19, IT-1512/22 and KK-2019/00-49), Xunta de Galicia (ED431C 2022/20 and ED431G 2019/02) and European Regional Development Fund (ERDF). P.K. thanks the German Research Foundation DFG for Heisenberg Professorship KO4095/5-1. S.S.O. and R.S. thank the PTQ-17-09103 (Ayuda Torres Quevedo, Ministerio de Ciencia e Innovación), and BioExcel-2 (Grant Number 823830, Horizon2020). M.B. was in part supported by an operating grant (# PJT 183758) from the Canadian Institute for Health Research. I.M-A. was the recipient of a predoctoral fellowship from the Basque Government. The authors would like to thank the staff members of the Basque Institute of Legal Medicine for their cooperation in the study, especially to Dr. Benito Morentin. R.D-A., T.M.S, D.A.G., I.M.A., A.S., P.K. and J.S. are members of COST Action CA18133 “ERNEST”.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)

  • Graziano, Giovanni
  • Delre, Pietro
  • Carofiglio, Francesca
  • Brea Floriani, José Manuel
  • Ligresti, Alessia
  • Kostrzewa, Magdalena
  • Riganti, Chiara
  • Gioé Gallo, Claudia
  • Majellaro, María
  • Nicolotti, Orazio
  • Colabufo, Nicola Antonio
  • Abate, Carmen
  • Loza García, María Isabel
  • Sotelo Pérez, Eddy
  • Mangiatordi, Giuseppe Felice
  • Contino, Marialessandra
  • Stefanachi, Angela
  • Leonetti, Francesco
Cannabinoid type 2 receptor (CB2R) is a G-protein-coupled receptor that, together with Cannabinoid type 1 receptor (CB1R), endogenous cannabinoids and enzymes responsible for their synthesis and degradation, forms the EndoCannabinoid System (ECS). In the last decade, several studies have shown that CB2R is overexpressed in activated central nervous system (CNS) microglia cells, in disorders based on an inflammatory state, such as neurodegenerative diseases, neuropathic pain, and cancer. For this reason, the anti-inflammatory and immune-modulatory potentials of CB2R ligands are emerging as a novel therapeutic approach. The design of selective ligands is however hampered by the high sequence homology of transmembrane domains of CB1R and CB2R. Based on a recent three-arm pharmacophore hypothesis and latest CB2R crystal structures, we designed, synthesized, and evaluated a series of new N-adamantyl-anthranil amide derivatives as CB2R selective ligands. Interestingly, this new class of compounds displayed a high affinity for human CB2R along with an excellent selectivity respect to CB1R. In this respect, compounds exhibiting the best pharmacodynamic profile in terms of CB2R affinity were also evaluated for the functional behavior and molecular docking simulations provided a sound rationale by highlighting the relevance of the arm 1 substitution to prompt CB2R action. Moreover, the modulation of the pro- and anti-inflammatory cytokines production was also investigated to exert the ability of the best compounds to modulate the inflammatory cascade
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Rapid traversal of vast chemical space using machine learning-guided docking screens

  • Luttens, Andreas
  • Cabeza de Vaca, Israel
  • Sparring, Leonard
  • Brea Floriani, José Manuel
  • Martínez Rodríguez, Antón Leandro
  • Kahlous, Nour Aldin
  • Radchenko, Dmytro S.
  • Moroz, Yurii S.
  • Loza García, María Isabel
  • Norinder, Ulf
  • Carlsson, Jens
The accelerating growth of make-on-demand chemical libraries provides unprecedented opportunities to identify starting points for drug discovery with virtual screening. However, these multi-billion-scale libraries are challenging to screen, even for the fastest structure-based docking methods. Here we explore a strategy that combines machine learning and molecular docking to enable rapid virtual screening of databases containing billions of compounds. In our workflow, a classification algorithm is trained to identify top-scoring compounds based on molecular docking of 1 million compounds to the target protein. The conformal prediction framework is then used to make selections from the multi-billion-scale library, reducing the number of compounds to be scored by docking. The CatBoost classifier showed an optimal balance between speed and accuracy and was used to adapt the workflow for screens of ultralarge libraries. Application to a library of 3.5 billion compounds demonstrated that our protocol can reduce the computational cost of structure-based virtual screening by more than 1,000-fold. Experimental testing of predictions identified ligands of G protein-coupled receptors and demonstrated that our approach enables discovery of compounds with multi-target activity tailored for therapeutic effect
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

  • Kossatz, Elk
  • Díez Alarcia, Rebeca
  • Gaitonde, Supriya A.
  • Ramón Duaso, Carla
  • Stepniewski, Tomasz Maciej
  • Aranda García, David
  • Muneta Arrate, Itziar
  • Tepaz, Elodie
  • Saen Oon, Suwipa
  • Soliva, Robert
  • Shahraki, Aida
  • Moreira, David
  • Brea Floriani, José Manuel
  • Loza García, María Isabel
  • Torre, Rafael de la
  • Kolb, Peter
  • Bouvier, Michel
  • Meana, J. Javier
  • Robledo, Patricia
  • Selent, Jana
G protein-coupled receptors (GPCRs) are sophisticated signaling machines able to simultaneously elicit multiple intracellular signaling pathways upon activation. Complete (in)activation of all pathways can be counterproductive for specific therapeutic applications. This is the case for the serotonin 2 A receptor (5-HT2AR), a prominent target for the treatment of schizophrenia. In this study, we elucidate the complex 5-HT2AR coupling signature in response to different signaling probes, and its physiological consequences by combining computational modeling, in vitro and in vivo experiments with human postmortem brain studies. We show how chemical modification of the endogenous agonist serotonin dramatically impacts the G protein coupling profile of the 5-HT2AR and the associated behavioral responses. Importantly, among these responses, we demonstrate that memory deficits are regulated by Gαq protein activation, whereas psychosis-related behavior is modulated through Gαi1 stimulation. These findings emphasize the complexity of GPCR pharmacology and physiology and open the path to designing improved therapeutics for the treatment of stchizophrenia
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits

  • Kossatz de Mello, Elk, 1977-
  • Diez Alarcia, Rebeca
  • Gaitonde, Supriya A.
  • Ramon Duaso, Carla, 1987-
  • Stepniewski, Tomasz Maciej, 1988-
  • Aranda García, David
  • Muneta Arrate, Itziar
  • Tepaz, Elodie
  • Saen-Oon, Suwipa
  • Soliva, Robert
  • Shahraki, Aida
  • Moreira, David
  • Brea, José
  • Loza, María I.
  • Torre Fornell, Rafael de la
  • Kolb, Peter
  • Bouvier, Michel
  • Meana, J. Javier
  • Robledo, Patricia, 1958-
  • Selent, Jana
G protein-coupled receptors (GPCRs) are sophisticated signaling machines able to simultaneously elicit multiple intracellular signaling pathways upon activation. Complete (in)activation of all pathways can be counterproductive for specific therapeutic applications. This is the case for the serotonin 2 A receptor (5-HT2AR), a prominent target for the treatment of schizophrenia. In this study, we elucidate the complex 5-HT2AR coupling signature in response to different signaling probes, and its physiological consequences by combining computational modeling, in vitro and in vivo experiments with human postmortem brain studies. We show how chemical modification of the endogenous agonist serotonin dramatically impacts the G protein coupling profile of the 5-HT2AR and the associated behavioral responses. Importantly, among these responses, we demonstrate that memory deficits are regulated by Gαq protein activation, whereas psychosis-related behavior is modulated through Gαi1 stimulation. These findings emphasize the complexity of GPCR pharmacology and physiology and open the path to designing improved therapeutics for the treatment of stchizophrenia., This work was supported by the ERAnet NEURON consortium fund (funding was provided by CIHR NDD-161471 and FRQ-S 278647 for M.B., the German Federal Ministry of Education and Research under grant number 01EW1909 for P.K., as well as the Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional number AC18/00030 for J.S. and P.R.). This work was further supported by the Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union (PI18/00094) to J.S. and (PI18/00053) to P.R. We acknowledge grant support from Agencia Estatal de Investigación (PID2020-119428RB-I00; SAF2017-88126R), Basque Government (IT-1211/19, IT-1512/22 and KK-2019/00-49), Xunta de Galicia (ED431C 2022/20 and ED431G 2019/02) and European Regional Development Fund (ERDF). P.K. thanks the German Research Foundation DFG for Heisenberg Professorship KO4095/5-1. S.S.O. and R.S. thank the PTQ-17-09103 (Ayuda Torres Quevedo, Ministerio de Ciencia e Innovación), and BioExcel-2 (Grant Number 823830, Horizon2020). M.B. was in part supported by an operating grant (# PJT 183758) from the Canadian Institute for Health Research. I.M-A. was the recipient of a predoctoral fellowship from the Basque Government. The authors would like to thank the staff members of the Basque Institute of Legal Medicine for their cooperation in the study, especially to Dr. Benito Morentin. R.D-A., T.M.S, D.A.G., I.M.A., A.S., P.K. and J.S. are members of COST Action CA18133 “ERNEST”.